FindMyRecallSubscribe
Class I: serious health riskTerminated

Hospira Lidocaine HCl Injection Recall

Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Via…

Hospira Inc. · Lake Forest, IL

Risk level
Class I
Reported by FDA
Oct 22, 2014
Recall ID
D-0020-2015
Check your lot numberHow we source this data

Summary

Hospira recalled Lidocaine HCl Injection starting Jul 29, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-0020-2015 on Oct 22, 2014. Reason: Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.

Product description

Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vial, Rx only, For Infiltration and Nerve Block including Epidural and Caudal, Manufactured by: Hospira, Inc., Lake Forest, IL, 60045, NDC 0409-2066-05

Lot numbers, UPCs & expiration codes

Lot Number: 25-550-DD, Exp: 1JAN2015

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0020-2015
Classification
Class I
Status
Terminated
Recall initiated
Jul 29, 2014
FDA report date
Oct 22, 2014
Quantity
109,110 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-0020-2015, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
68901
Address
275 N Field Dr
Code information
Lot Number: 25-550-DD, Exp: 1JAN2015
Postal code
60045-2579
Report date
Oct 22, 2014
Product type
Drugs
Recall number
D-0020-2015
Classification
Class I
Recalling firm
Hospira Inc.
Product quantity
109,110 Vials
Termination date
Mar 17, 2017
Reason for recall
Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vial, Rx only, For Infiltration and Nerve Block including Epidural and Caudal, Manufactured by: Hospira, Inc., Lake Forest, IL, 60045, NDC 0409-2066-05
Distribution pattern
Nationwide
Recall initiation date
Jul 29, 2014
Initial firm notification
Press Release
Center classification date
Oct 10, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0020-2015, published Oct 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls